{"data":[{"accessionNo":"0002005369-26-000053","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-11","reportingPerson":"Raymond Debbane","reportingCik":null,"personType":"IN","sharesOwned":675000,"percentOfClass":7.2,"filedAt":"2026-09-17"},{"accessionNo":"0002005369-26-000053","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-11","reportingPerson":"Invus Public Equities, L.P.","reportingCik":null,"personType":"PN","sharesOwned":591472,"percentOfClass":6.3,"filedAt":"2026-09-17"},{"accessionNo":"0002005369-26-000053","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-11","reportingPerson":"Siren, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":591472,"percentOfClass":6.3,"filedAt":"2026-09-17"},{"accessionNo":"0002005369-26-000053","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-11","reportingPerson":"Invus Global Management, LLC","reportingCik":null,"personType":"OO","sharesOwned":591472,"percentOfClass":6.3,"filedAt":"2026-09-17"},{"accessionNo":"0002005369-26-000053","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-11","reportingPerson":"Invus Public Equities Advisors, LLC","reportingCik":null,"personType":"OO","sharesOwned":591472,"percentOfClass":6.3,"filedAt":"2026-09-17"},{"accessionNo":"0002005369-26-000053","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-11","reportingPerson":"Ulys, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":83528,"percentOfClass":0.9,"filedAt":"2026-09-17"},{"accessionNo":"0002005369-26-000053","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-11","reportingPerson":"Avicenna Life Sci Master GP LLC","reportingCik":null,"personType":"OO","sharesOwned":83528,"percentOfClass":0.9,"filedAt":"2026-09-17"},{"accessionNo":"0002005369-26-000053","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-11","reportingPerson":"Avicenna Life Sci Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":83528,"percentOfClass":0.9,"filedAt":"2026-09-17"},{"accessionNo":"0000905148-26-003761","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-07-27","reportingPerson":"venBio Global Strategic GP V, LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":279340,"percentOfClass":9.99,"filedAt":"2026-08-14"},{"accessionNo":"0000905148-26-003761","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-07-27","reportingPerson":"venBio Global Strategic Fund V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":279340,"percentOfClass":9.99,"filedAt":"2026-08-14"},{"accessionNo":"0001104659-26-097426","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":59000,"percentOfClass":8.8,"filedAt":"2026-08-14"},{"accessionNo":"0001104659-26-097426","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":59000,"percentOfClass":8.8,"filedAt":"2026-08-14"},{"accessionNo":"0002140685-26-000004","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"common stock, par value $0.0001","eventDate":"2026-08-13","reportingPerson":"Zhang Xiaofan","reportingCik":null,"personType":"IN","sharesOwned":162452,"percentOfClass":0.6,"filedAt":"2026-08-13"},{"accessionNo":"0000935836-26-000377","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-31","reportingPerson":"Logos Global Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":286308,"percentOfClass":10.7,"filedAt":"2026-08-07"},{"accessionNo":"0000935836-26-000377","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-31","reportingPerson":"Arsani William","reportingCik":null,"personType":"HC,IN","sharesOwned":286308,"percentOfClass":10.7,"filedAt":"2026-08-07"},{"accessionNo":"0000935836-26-000377","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-31","reportingPerson":"Logos Global Management GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":286308,"percentOfClass":10.7,"filedAt":"2026-08-07"},{"accessionNo":"0001274173-26-000185","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"YARROW BIOSCIENCE, INC.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock","eventDate":"2026-07-31","reportingPerson":"JANUS HENDERSON GROUP Ltd.","reportingCik":null,"personType":"HC","sharesOwned":266712,"percentOfClass":9.99,"filedAt":"2026-08-07"},{"accessionNo":"0000935836-26-000377","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-31","reportingPerson":"Logos Global Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":176678,"percentOfClass":6.6,"filedAt":"2026-08-07"},{"accessionNo":"0000935836-26-000377","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-31","reportingPerson":"Logos GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":176678,"percentOfClass":6.6,"filedAt":"2026-08-07"},{"accessionNo":"0000935836-26-000377","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-31","reportingPerson":"Graham Walmsley","reportingCik":null,"personType":"HC,IN","sharesOwned":109630,"percentOfClass":4.1,"filedAt":"2026-08-07"},{"accessionNo":"0000935836-26-000377","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-31","reportingPerson":"Logos Opportunities Fund V LP","reportingCik":null,"personType":"PN","sharesOwned":109630,"percentOfClass":4.1,"filedAt":"2026-08-07"},{"accessionNo":"0000935836-26-000377","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-31","reportingPerson":"Logos Opportunities V GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":109630,"percentOfClass":4.1,"filedAt":"2026-08-07"},{"accessionNo":"0000947871-26-000747","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"COMMON STOCK","eventDate":"2026-07-27","reportingPerson":"ORBIMED ADVISORS LLC","reportingCik":"0001055951","personType":"IA","sharesOwned":266306,"percentOfClass":9.97,"filedAt":"2026-08-05"},{"accessionNo":"0000947871-26-000747","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"COMMON STOCK","eventDate":"2026-07-27","reportingPerson":"OrbiMed Capital GP X LLC","reportingCik":"0002140741","personType":"OO","sharesOwned":233019,"percentOfClass":8.73,"filedAt":"2026-08-05"},{"accessionNo":"0000947871-26-000747","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"COMMON STOCK","eventDate":"2026-07-27","reportingPerson":"OrbiMed Capital GP X, LP","reportingCik":"0002148682","personType":"OO","sharesOwned":233019,"percentOfClass":8.73,"filedAt":"2026-08-05"},{"accessionNo":"0000947871-26-000747","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"COMMON STOCK","eventDate":"2026-07-27","reportingPerson":"OrbiMed Genesis GP LLC","reportingCik":"0001808744","personType":"OO","sharesOwned":33287,"percentOfClass":1.25,"filedAt":"2026-08-05"},{"accessionNo":"0000935836-26-000371","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-27","reportingPerson":"Logos Global Management GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":276704,"percentOfClass":9.9,"filedAt":"2026-08-04"},{"accessionNo":"0000935836-26-000371","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-27","reportingPerson":"Logos Global Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":276704,"percentOfClass":9.9,"filedAt":"2026-08-04"},{"accessionNo":"0000935836-26-000371","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-27","reportingPerson":"Logos Opportunities V GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":256704,"percentOfClass":9.9,"filedAt":"2026-08-04"},{"accessionNo":"0000935836-26-000371","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-27","reportingPerson":"Logos Opportunities Fund V LP","reportingCik":null,"personType":"PN","sharesOwned":256704,"percentOfClass":9.9,"filedAt":"2026-08-04"},{"accessionNo":"0000935836-26-000371","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-27","reportingPerson":"Logos GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":120026,"percentOfClass":9.9,"filedAt":"2026-08-04"},{"accessionNo":"0000935836-26-000371","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-27","reportingPerson":"Logos Global Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":120026,"percentOfClass":9.9,"filedAt":"2026-08-04"},{"accessionNo":"0000935836-26-000371","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-27","reportingPerson":"Arsani William","reportingCik":null,"personType":"HC,IN","sharesOwned":276704,"percentOfClass":9.9,"filedAt":"2026-08-04"},{"accessionNo":"0000935836-26-000371","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-07-27","reportingPerson":"Graham Walmsley","reportingCik":null,"personType":"HC,IN","sharesOwned":256704,"percentOfClass":9.9,"filedAt":"2026-08-04"},{"accessionNo":"0001193125-26-330498","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-07-27","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":266756,"percentOfClass":9.99,"filedAt":"2026-08-03"},{"accessionNo":"0001193125-26-330498","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-07-27","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":266756,"percentOfClass":9.99,"filedAt":"2026-08-03"},{"accessionNo":"0001193125-26-330498","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-07-27","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":266756,"percentOfClass":9.99,"filedAt":"2026-08-03"},{"accessionNo":"0001104659-26-088671","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common stock, par value $0.0001","eventDate":"2026-07-27","reportingPerson":"Roderick Wong","reportingCik":null,"personType":"HC,IN","sharesOwned":266307,"percentOfClass":9.99,"filedAt":"2026-07-30"},{"accessionNo":"0001104659-26-088671","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common stock, par value $0.0001","eventDate":"2026-07-27","reportingPerson":"RTW Fund Group GP, LLC","reportingCik":null,"personType":"IA,HC","sharesOwned":266307,"percentOfClass":9.99,"filedAt":"2026-07-30"},{"accessionNo":"0001193125-26-323654","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-27","reportingPerson":"Access Industries Management, LLC","reportingCik":"0001508226","personType":"OO","sharesOwned":178180,"percentOfClass":6.02,"filedAt":"2026-07-29"},{"accessionNo":"0001193125-26-323654","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-27","reportingPerson":"Len Blavatnik","reportingCik":"0001326628","personType":"IN","sharesOwned":178180,"percentOfClass":6.02,"filedAt":"2026-07-29"},{"accessionNo":"0001193125-26-323654","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-27","reportingPerson":"AI Biotechnology LLC","reportingCik":"0001942670","personType":"OO","sharesOwned":178180,"percentOfClass":6.02,"filedAt":"2026-07-29"},{"accessionNo":"0001193125-26-323654","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"Yarrow Bioscience, Inc.","ticker":"YARW","cusip":"92941V407","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-27","reportingPerson":"Access Industries Holdings LLC","reportingCik":"0001391297","personType":"OO","sharesOwned":178180,"percentOfClass":6.02,"filedAt":"2026-07-29"},{"accessionNo":"0002140685-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":"92941V308","securityClass":"common stock, par value $0.0001","eventDate":"2026-06-08","reportingPerson":"Zhang Xiaofan","reportingCik":null,"personType":null,"sharesOwned":null,"percentOfClass":null,"filedAt":"2026-07-17"},{"accessionNo":"0002140685-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":"92941V308","securityClass":"common stock, par value $0.0001","eventDate":"2026-07-13","reportingPerson":"Zhang Xiaofan","reportingCik":null,"personType":null,"sharesOwned":null,"percentOfClass":null,"filedAt":"2026-07-14"},{"accessionNo":"0002140685-26-000001","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":"92941V308","securityClass":"common stock, par value $0.0001","eventDate":"2026-06-08","reportingPerson":"Zhang Xiaofan","reportingCik":null,"personType":"IN","sharesOwned":1873388,"percentOfClass":5.6,"filedAt":"2026-06-15"},{"accessionNo":"0001104659-26-062664","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":"92941V308","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-03-31","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":2000000,"percentOfClass":6,"filedAt":"2026-05-15"},{"accessionNo":"0001104659-26-062664","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":"92941V308","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-03-31","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":2000000,"percentOfClass":6,"filedAt":"2026-05-15"},{"accessionNo":"0001104659-26-062664","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":"92941V308","securityClass":"Common Stock, par value $0.0001","eventDate":"2026-03-31","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":2000000,"percentOfClass":6,"filedAt":"2026-05-15"},{"accessionNo":"0001104659-25-112496","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":null,"securityClass":"Common Stock, par value $0.0001 (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Citadel Advisors Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":3669,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001104659-25-112496","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":null,"securityClass":"Common Stock, par value $0.0001 (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Citadel Securities LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":63,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001104659-25-112496","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":null,"securityClass":"Common Stock, par value $0.0001 (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Citadel Advisors LLC","reportingCik":null,"personType":"IA,HC,OO","sharesOwned":3669,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001104659-25-112496","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":null,"securityClass":"Common Stock, par value $0.0001 (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Citadel Securities Group LP","reportingCik":null,"personType":"HC,PN","sharesOwned":63,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001104659-25-112496","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":null,"securityClass":"Common Stock, par value $0.0001 (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Citadel Securities GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":63,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001104659-25-112496","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":null,"securityClass":"Common Stock, par value $0.0001 (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Kenneth Griffin","reportingCik":null,"personType":"HC,IN","sharesOwned":3732,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001172661-25-004954","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001172661-25-004954","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001580642-25-007308","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":null,"securityClass":"Common Stock, par value $0.0001","eventDate":"2025-09-30","reportingPerson":"Eventide Asset Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001580642-25-007308","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":null,"securityClass":"Common Stock, par value $0.0001","eventDate":"2025-09-30","reportingPerson":"Finny Kuruvilla, M.D. Ph. D.","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001580642-25-007308","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":null,"securityClass":"Common Stock, par value $0.0001","eventDate":"2025-09-30","reportingPerson":"Robin C. John","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001104659-25-112496","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001566044","issuerName":"VYNE Therapeutics Inc.","ticker":"YARW","cusip":null,"securityClass":"Common Stock, par value $0.0001 (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Citadel GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":3669,"percentOfClass":0,"filedAt":"2025-11-14"}],"updatedAt":"2026-09-19T08:13:52.402Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}